Search Results - "Ahuja, Tarry"

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration by Parmar, Ambica, Dai, Wei Fang, Dionne, Francois, Geirnaert, Marc, Denburg, Avram, Ahuja, Tarry, Beca, Jaclyn, Bouchard, Sylvie, Chambers, Carole, Hunt, Melissa J, Husereau, Don, Lungu, Elena, McDonald, Valerie, Mercer, Rebecca E, Mitera, Gunita, Muñoz, Caroline, Naipaul, Rohini, Peacock, Stuart, Potashnik, Tanya, Tadrous, Mina, Takhar, Pam, Taylor, Marianne, Trudeau, Maureen, Wasney, Danica, Gavura, Scott, Chan, Kelvin K W

“…The Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration developed an MCDA rating tool to assess and prioritize potential…”
Get full text

Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle by Tadrous, Mina, Ahuja, Tarry, Ghosh, Basanti, Kropp, Rhonda

“…Policy makers face challenges with the number of drugs for rare indications and rapidly rising costs. In facing these challenges, decision-makers see…”
Get full text

Preliminary efficacy of optimal pharmacotherapy and patient views in multiple myeloma by Manoharan, Amanda S., Haines, Alex, Assasi, Nazila, Bryan, Matthew, Boucher, Julie, Gauthier, Graham, Douma, Reuben, Smith, Andrea, Butcher, Robyn, Ahuja, Tarry, de Leseleuc, Louis, Dyrda, Peter, Blommestein, Hedwig M., Thielen, Fredrick W., Leeneman, Brenda

“…e20006 Background: As new agents are approved for multiple myeloma (MM) and existing drugs become generic, treatments that represent optimal use of healthcare…”
Get full text

How Collaboration Can Bring about Change: Effective Knowledge Translation on Self-monitoring of Blood Glucose by Ahuja, Tarry, Taylor, Suzanne, Dossa, Anar, Vosilla, Ann, Pang, Walton, Mira, Aileen, Jennings, Sarah

Get full text